Liposome Company
Executive Summary
National Technical Information Service intends to grant the company exclusive U.S. rights to manufacture, use and sell products resulting from patent on "New Antiretroviral Agents and Delivery System for Same," the government announced in a March 31 Federal Register notice. Comments are being accepted until May 30.